192Ir is an ideal radioisotope for interstitial brachytherapy in veterinary medicine because of its 74.2-day half-life, medium-energy gamma radiation (0.35 MeV), moderate shielding requirements, low cost, and adaptability to most tumor configurations. The afterloading technique can easily be applied ...
Radioisotope Ir-192 is normally produced by neutron activation of natural-abundance iridium metal, usually in nuclear reactors. The strength (or specific activity) of a resulting Ir-192 is related to the amount of neutron irradiation and length of time to which the natural-abundance iridium metal ...
Radiation Medicine UnitMedical PhysicsAstrahan, " A Localized Current Field Hyperthermia System for Use with 192—Iridium Interstitial Implants " Medical Physics, 9 (3), May/Jun. 1982.Melvin A. Astrahan, " A Localized Current Field Hyperthermia System for Use with 192-Iridium Interstitial Implants...
Radioisotope Ir-192 is normally produced by neutron activation of natural-abundance iridium metal, usually in nuclear reactors. The strength (or specific activity) of a resulting Ir-192 is related to the amount of neutron irradiation and length of time to which the natural-abundance iridium metal...
3 Combined interstitial Iridium-192 implant and external beam irradiation in the treatment of carcinoma of the prostateDialysisBlood flowRenal disease Biomedical engineering Biochemical engineering MedicinePurpose: to assess the impact of local tumor control on ultimate disease free survival. Materials and ...
In areas linked to medicine, Ir has been used together with Pt as a component of electrodes for stimulation. In oncology, the Ir192 isotope lends itself to brachytherapy with a half-life of only 74 days. Ir can be used in after-loading systems that protect medical personnel from radiation ...
The possibilities of Ir192 as a source of gamma-rays for tele-therapeutic units were investigated, and the design of a complete unit is described. An output of about 11 r/min. at 8 cm. f.s.d. is obtained from a unit weighting 50 lbs., which nevertheless has sufficient lead protection...
41, p. 192. https://doi.org/10.1039/C1CS15009J Article PubMed Google Scholar Letertre, M.P.M., Giraudeau, P., and de Tullio, P., Nuclear magnetic resonance spectroscopy in clinical metabolomics and personalized medicine: Current challenges and perspectives, Front. Mol. Biosci., 2021, ...
radiology and nuclear medicineneoplasmsradiotherapyprostateiridiumpatientsradiation dosesbeta decay radioisotopesbeta-minus decay radioisotopesbeta-plus decay radioisotopesAggressive radiotherapy was used in 170 patients with advanced of the prostate. After pelvic lymphadenectomy, 192Ir brachytherapy was used to ...
doi:10.1007/s13246-017-0568-9Pooya, S. M. HosseiniAEOIDashtipour, M. RAEOIPaydar, RIran Univ Med SciMianji, FAEOIPourshahab, BAEOISpringer NetherlandsAustralasian Physical & Engineering Sciences in Medicine